title: Imatinib: can one outwit chronic myeloid leukemia?
authors.forename: Lucio
authors.initials: L
authors.lastname: Luzzatto
authors.forename: Francesco
authors.initials: F
authors.lastname: Frassoni
authors.forename: Junia V
authors.initials: JV
authors.lastname: Melo
mesh_terms: D001549:Benzamides; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D016313:Genes, abl / Q000235:genetics; D006801:Humans; D000068877:Imatinib Mesylate; D007951:Leukemia, Myeloid / Q000188:drug therapy* / Q000235:genetics; D010879:Piperazines / Q000627:therapeutic use*; D017354:Point Mutation; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism; D011743:Pyrimidines / Q000627:therapeutic use*
chemical_list: D001549:Benzamides; D004791:Enzyme Inhibitors; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D011505:Protein-Tyrosine Kinases